Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Cash (2022 - 2025)

Historic Change in Cash for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $486.0 million.

  • GE HealthCare Technologies' Change in Cash rose 17157.58% to $486.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 31937.98%. This contributed to the annual value of $1.6 billion for FY2025, which is 31937.98% up from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Change in Cash is $486.0 million, which was up 17157.58% from $264.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Change in Cash ranged from a high of $1.6 billion in Q3 2024 and a low of -$679.0 million during Q4 2024
  • In the last 4 years, GE HealthCare Technologies' Change in Cash had a median value of $72.5 million in 2023 and averaged $247.2 million.
  • Data for GE HealthCare Technologies' Change in Cash shows a peak YoY increase of 192692.31% (in 2023) and a maximum YoY decrease of 172083.33% (in 2023) over the last 5 years.
  • GE HealthCare Technologies' Change in Cash (Quarter) stood at $947.0 million in 2022, then plummeted by 90.92% to $86.0 million in 2023, then crashed by 889.53% to -$679.0 million in 2024, then surged by 171.58% to $486.0 million in 2025.
  • Its Change in Cash was $486.0 million in Q4 2025, compared to $264.0 million in Q3 2025 and $1.3 billion in Q2 2025.